Theriva™ Biologics to Discuss the Trial Design for VIRAGE – a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma – at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

10d ago

TOVX

PremiumCompany Announcements

Theriva Biologics’ VCN-01 Shows Promise in Pediatric Cancer Trial

12d ago

TOVX

PremiumThe Fly

Theriva Biologics announces topline data from Phase 1 trial of VCN-01

12d ago

TOVX

PremiumCompany Announcements

Theriva Biologics Reports Breakthrough in Pancreatic Cancer Therapy

12d ago

TOVX

PremiumPress Releases

Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting

12d ago

TOVX

PremiumCompany Announcements

Theriva Biologics Upcoming Investor Presentations Insight

19d ago

TOVX

More TOVX News >

SFY News on the Web

2024-03-27

Buy Recommendation for Theriva Biologics Backed by Promising Oncolytic Adenovirus Platform and Clinical Trial Advancements

TipRanks News

Bullish

2024-03-26

Theriva Biologics, Inc. Q4 2023 Earnings Call Transcript

Yahoo Finance

Bullish

2024-03-26

Q4 2023 Theriva Biologics Inc Earnings Call Transcript

GuruFocus News

Neutral

2024-03-19

Theriva™ Biologics to Host Conference Call and Webcast to Discuss Full Year 2023 Operational Highlights and Financial Results

Yahoo Finance

Neutral

2024-03-11

Theriva™ Biologics to Participate in the BIO-Europe Spring Conference

Yahoo Finance

Neutral

2024-01-16

Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference

Yahoo Finance

Neutral

2023-12-05

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

Yahoo Finance

Neutral

2023-11-20

Theriva Biologics, Inc. Q3 2023 Earnings Call Transcript

Yahoo Finance

Neutral

News Score - Last 7 Days

Positive

DE:SFY

Sector Average

Media Buzz

This Week3 articles

Weekly Average1.25 articles

News Sentiment

This Week100%

Sector Average64%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:SFY’s Media Buzz Sentiment?

3 articles about DE:SFY were published this week. In an average week, 1.25 articles are published.

What is DE:SFY’s weekly average amount of articles?

In an average week, 1.25 articles about DE:SFY are published.

What is DE:SFY’s News Sentiment?

100% of articles about DE:SFY were positive this week, compared to its sector average of 64%.

Healthcare Stocks that are Trending in the News

STROSutro Biopharma

MASIMasimo

THRDThird Harmonic Bio, Inc.

STOKStoke Therapeutics

BCABBioAtla

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing